Wnt pathway mutations selected by optimal β‐catenin signaling for tumorigenesis
- 5 June 2006
- journal article
- Published by Wiley in FEBS Letters
- Vol. 580 (15) , 3665-3670
- https://doi.org/10.1016/j.febslet.2006.05.053
Abstract
Mutations in components of the Wnt/beta-catenin pathway are observed to be the earliest initiating event for most colorectal tumors. The majority of the mutations occur in the tumor suppressor adenomatous polyposis coli (APC), even though there are other genes that are capable of modulating the pathway activity. Moreover, the specific APC mutations associated in colon cancer indicate the possibility that the tumor selects for certain truncated forms of APC that partially retain its function, namely, inhibition of beta-catenin. We estimated the effects of various mutations in APC and other known mutations using a recent mathematical model of the Wnt pathway that was constructed to represent the conserved core molecular events. We provide evidence that APC mutations are selected not based on the maximal level of beta-catenin but rather based on distinct state of activity that appears to be optimal for the tissue-specific tumorigenesis. This optimal level is determined by balancing beta-catenin signaling and the induction of Axin2 that acts as a potent negative feedback. The predominant pattern of APC mutations may provide synergistic oncogenic effects that promote colorectal tumorigenesis: the optimal signaling for cell survival and renewal, disrupted cell adhesion, chromosomal instability, and altered asymmetric division of stem cells.Keywords
This publication has 13 references indexed in Scilit:
- APC dosage effects in tumorigenesis and stem cell differentiationThe International Journal of Developmental Biology, 2004
- The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt PathwayPLoS Biology, 2003
- Tumor formation by genetic mutations in the components of the Wnt signaling pathwayCancer Science, 2003
- The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascadeHuman Molecular Genetics, 2002
- Activation of AXIN2 Expression by β-Catenin-T Cell FactorJournal of Biological Chemistry, 2002
- Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver TumorsMolecular and Cellular Biology, 2002
- Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/β-catenin signaling is activated in human colon tumorsProceedings of the National Academy of Sciences, 2001
- APC, Signal transduction and genetic instability in colorectal cancerNature Reviews Cancer, 2001
- The ABC of APCHuman Molecular Genetics, 2001
- Control of β-Catenin StabilityMolecular Cell, 2000